CRISTINE ESPINOSA: Open Payments
NPI 1871850230 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $77 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Dexcom, Inc. | 2 | $43 |
| Amgen Inc. | 2 | $30 |
| Lilly USA, LLC | 1 | $26 |
| Novo Nordisk Inc | 1 | $20 |
| Verona Pharma, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: LEQVIO, REXULTI, VRAYLAR, Dexcom G6 Transmitter, UBRELVY, JARDIANCE, Ozempic, Ohtuvayre.
Industry payments across NY — which companies pay providers there.
